Sunshine Biopharma

(NASDAQ) SBFM

Current Price$1.05

Market Cap$4.72M

Since IPO (2009)-100%

5 Year-100%

1 Year-29%

1 Month-7%

Sunshine Biopharma Financials at a Glance

Market Cap

$4.72M

Revenue (TTM)

$36.31M

Net Income (TTM)

$5.98M

EPS (TTM)

$-1.48

P/E Ratio

-0.65

Dividend

$0.00

Beta (Volatility)

0.89 (Low)

Dividend

$0.00

Beta (Volatility)

0.89 (Low)

Price

$1.05

Volume

1,653

Open

$0.97

Price

$1.05

Volume

1,653

Open

$0.97

Previous Close

$1.05

Daily Range

$0.97 - $1.05

52-Week Range

$0.95 - $2.43

Dividend

$0.00

Beta (Volatility)

0.89 (Low)

Price

$1.05

Volume

1,653

Open

$0.97

Previous Close

$1.05

Daily Range

$0.97 - $1.05

52-Week Range

$0.95 - $2.43

SBFM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sunshine Biopharma

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Steve N. Slilaty, PhD

Website

www.sunshinebiopharma.com

Headquarters

Pointe-Claire, QC H9R 0A5, CA

SBFM Financials

Key Financial Metrics (TTM)

Gross Margin

33%

Operating Margin

-12%

Net Income Margin

-16%

Return on Equity

-26%

Return on Capital

-19%

Return on Assets

-20%

Earnings Yield

-1.54%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.72M

Shares Outstanding

4.91M

Volume

1.65K

Avg. Volume

35.72K

Financials (TTM)

Gross Profit

$11.92M

Operating Income

$4.48M

EBITDA

$4.15M

Operating Cash Flow

$5.33M

Capital Expenditure

$174.49K

Free Cash Flow

$5.51M

Cash & ST Invst.

$9.12M

Total Debt

$812.42K

Sunshine Biopharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$8.58M

-10.6%

Gross Profit

$2.93M

-5.3%

Gross Margin

34.16%

N/A

Market Cap

$4.72M

N/A

Market Cap/Employee

$90.79K

N/A

Employees

N/A

Net Income

$2.14M

+0.8%

EBITDA

$1.56M

+29.5%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$8.31M

-4.8%

Accounts Receivable

$3.46M

-10.6%

Inventory

$13.47M

+19.5%

Long Term Debt

$596.78K

-19.9%

Short Term Debt

$215.64K

+3.8%

Return on Assets

-19.86%

N/A

Return on Invested Capital

-18.95%

N/A

Free Cash Flow

$845.76K

+78.0%

Operating Cash Flow

$1.62M

+52.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LUCYInnovative Eyewear, Inc.

LUCYInnovative Eyewear, Inc.$1.03-1.43%

ACXPAcurx Pharmaceuticals, Inc.

ACXPAcurx Pharmaceuticals, Inc.$2.16+0.00%

SNOASonoma Pharmaceuticals, Inc.

SNOASonoma Pharmaceuticals, Inc.$1.20+9.09%

HCWBHCW Biologics Inc.

HCWBHCW Biologics Inc.$0.43-7.70%

PFSAProfusa, Inc. Common Stock

PFSAProfusa, Inc. Common Stock$0.56-5.79%

CHEKCheck-Cap Ltd.

CHEKCheck-Cap Ltd.$1.68-11.11%

IINNInspira Technologies Oxy B.H.N. Ltd.

IINNInspira Technologies Oxy B.H.N. Ltd.$0.47+5.76%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.05+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.68+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.33+0.03%

NIONio

NIONio$5.92-0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.21-0.03%

MARAMara Holdings

MARAMara Holdings$11.44-0.05%

FFord Motor Company

FFord Motor Company$11.88-0.02%

Questions About SBFM

What is the current price of Sunshine Biopharma?

Sunshine Biopharma is trading at $1.05 per share.

What is the 52-week range for Sunshine Biopharma?

Over the past 52 weeks, Sunshine Biopharma has traded between $0.95 and $2.43.

How much debt does Sunshine Biopharma have?

As of the most recent reporting period, Sunshine Biopharma reported total debt of $812,422.

How much cash does Sunshine Biopharma have on hand?

Sunshine Biopharma reported $9.12M in cash and cash equivalents in its most recent financial results.

What is Sunshine Biopharma’s dividend yield?

Sunshine Biopharma does not currently have a dividend yield.

Sunshine Biopharma

Sunshine Biopharma Financials at a Glance

SBFM News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Sunshine Biopharma

SBFM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Sunshine Biopharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SBFM

What is the current price of Sunshine Biopharma?

What is the 52-week range for Sunshine Biopharma?

How much debt does Sunshine Biopharma have?

How much cash does Sunshine Biopharma have on hand?

What is Sunshine Biopharma’s dividend yield?

Premium Investing Services